Delivery Order SPE2DR25D2018-SPE2DR26FZ0E0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count) on September 25, 2025, with a ceiling value of $8,590.58 and an ultimate completion date of October 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. OFEV (nintedanib) is a prescription medication used to treat idiopathic...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count) on August 12, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. OFEV (nintedanib) is a prescription medication used to treat idiopathic pulmonary fibrosis and...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on August 15, 2025, with completion targeted for September 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. OFEV (nintedanib) is a prescription medication used to treat idiopathic pulmonary fibrosis...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on September 9, 2025, with a completion date of September 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. OFEV (nintedanib) is a tyrosine kinase inhibitor primarily used in the treatment of idiopathic...
- The Defense Logistics Agency awarded a delivery order valued at $9,053.16 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on December 1, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. OFEV (nintedanib) is a specialty pharmaceutical used primarily for the treatment...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on September 4, 2025, with an ultimate completion date of September 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. OFEV (nintedanib) is a tyrosine kinase inhibitor used in the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $25,771.74 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on August 18, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. OFEV (nintedanib) is a specialty pharmaceutical used in the treatment of pulmonary fibrosis...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on August 19, 2025, with completion targeted for September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OFEV (150 mg capsule, 60-count units) valued at $8,316.81 under a firm fixed-price contract. The award was made on November 3, 2025, with an ultimate completion date of November 25, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. OFEV is a specialized pharmaceutical product used primarily in the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of OFEV (nintedanib) 100 mg capsules in quantities of 60 units, with a contract ceiling value of $8,630.28. This is a firm fixed-price delivery order with no set-aside designation, issued under open competition. The ultimate completion date is September 9, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. OFEV...
- SPE2DR25D2018Indefinite Delivery Contract
- SPE2DR25D2018-SPE2DR26FZ0E0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,053.16 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on December 10, 2025, with completion expected by January 2, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. OFEV (nintedanib) is a prescription medication indicated for idiopathic pulmonary fibrosis and other progressive fibrosing interstitial lung diseases, representing a specialized pharmaceutical supply need within the federal medical procurement system. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a substantial $999.99 billion vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support contract for military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal contract awards across multiple therapeutic domains and regularly fulfills medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through this prime vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 12/9/25 |